Latest JohnsonJohnson News and Updates : JohnsonJohnson updates, JohnsonJohnson News , JohnsonJohnson around the world

Nishadil

Washington | 21°C (overcast clouds)

Navigating the Market Currents: Why Analysts Are Reworking Key Stock Price Targets

Top story

Navigating the Market Currents: Why Analysts Are Reworking Key Stock Price Targets

In focus

Latest feed

Your Last-Minute Market Moves: Unpacking Today's 'Final Trades'

Why Wall Street is Betting Big on These Rock-Solid Dividend Aristocrats

Another Chapter Unfolds: Jury Finds Johnson & Johnson Liable in Baby Powder Cancer Case

Tylenol and Autism: Navigating New Research on Prenatal Acetaminophen Use

Latest headlines

NVIDIA's Current Quandary: Can the AI Kingpin Reignite Its Stock Performance?

NVIDIA's Current Quandary: Can the AI Kingpin Reignite Its Stock Performance?

Penumbra Shares Skyrocket: Is a Major Takeover Really Brewing?

Penumbra Shares Skyrocket: Is a Major Takeover Really Brewing?

The Shattered Trust: A Giant's Shadow Over Millions

The Shattered Trust: A Giant's Shadow Over Millions

Major Blow to Johnson & Johnson: Jury Awards $40 Million in Talcum Powder Cancer Case

Major Blow to Johnson & Johnson: Jury Awards $40 Million in Talcum Powder Cancer Case

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

The AI Showdown: Is Google's Gemini Poised to Shake Up the Tech Giants?

The AI Showdown: Is Google's Gemini Poised to Shake Up the Tech Giants?

Riding the Storm: Unpacking a Tumultuous Week in the Markets

Riding the Storm: Unpacking a Tumultuous Week in the Markets

The Great Sector Shuffle: Uncovering Tomorrow's Winners Amidst Market Flux

The Great Sector Shuffle: Uncovering Tomorrow's Winners Amidst Market Flux

The Quiet Confidence: Why Searle & Co. Just Doubled Down on Johnson & Johnson

The Quiet Confidence: Why Searle & Co. Just Doubled Down on Johnson & Johnson

Beyond Just Income: Why Wall Street's Savviest are Eyeing These Three Dividend Powerhouses

Beyond Just Income: Why Wall Street's Savviest are Eyeing These Three Dividend Powerhouses

The Tylenol Tangle: Texas Challenges a Phantom Autism Link

The Tylenol Tangle: Texas Challenges a Phantom Autism Link

The Unseen Cost? Texas Takes On Tylenol Makers Over Autism Link Claims

The Unseen Cost? Texas Takes On Tylenol Makers Over Autism Link Claims

Tylenol in the Crosshairs: Texas Families Seek Answers on Autism Allegations

Tylenol in the Crosshairs: Texas Families Seek Answers on Autism Allegations

The Dow's High Flyers: Can Earnings Sustain the Momentum?

The Dow's High Flyers: Can Earnings Sustain the Momentum?

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

The Talc Tempest: Johnson & Johnson Faces Cancer Claims and Billions in Legal Battles

The Talc Tempest: Johnson & Johnson Faces Cancer Claims and Billions in Legal Battles

Johnson & Johnson Considers Major Orthopedic Business Split

Johnson & Johnson Considers Major Orthopedic Business Split

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!

Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!

Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled

Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled

Johnson & Johnson Soars Past Expectations with Stellar Q3 Earnings, Driven by Pharmaceutical and MedTech Growth

Johnson & Johnson Soars Past Expectations with Stellar Q3 Earnings, Driven by Pharmaceutical and MedTech Growth

Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook

Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook

J&J's Q3 Rollercoaster: Stock Dip, MedTech Hopes, and Tariff Tangles!

J&J's Q3 Rollercoaster: Stock Dip, MedTech Hopes, and Tariff Tangles!

The S&P 500's Moment of Truth: Why the 20-Day Moving Average is the Market's Next Big Test

The S&P 500's Moment of Truth: Why the 20-Day Moving Average is the Market's Next Big Test

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

Momentum Mavericks: 5 Powerhouse Stocks Poised for Big Earnings Weeks Ahead

Momentum Mavericks: 5 Powerhouse Stocks Poised for Big Earnings Weeks Ahead

Wall Street Reacts: Top Stock Moves and Analyst Insights Shaping Thursday's Market

Wall Street Reacts: Top Stock Moves and Analyst Insights Shaping Thursday's Market

The Billions at Stake: Johnson & Johnson's Decisive Move in Talc Litigation

The Billions at Stake: Johnson & Johnson's Decisive Move in Talc Litigation

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

Is Pharma Poised for a Powerful Rebound? Chart Master Sees a Major Breakout Ahead

Is Pharma Poised for a Powerful Rebound? Chart Master Sees a Major Breakout Ahead

Navigating the AI Stock Landscape: Smart Bets Beyond the Hype, According to Trivariate

Navigating the AI Stock Landscape: Smart Bets Beyond the Hype, According to Trivariate

Unleash Your Potential: Johnson & Johnson's 'Dual Control' Empowers IBD Patients in Asia Pacific

Unleash Your Potential: Johnson & Johnson's 'Dual Control' Empowers IBD Patients in Asia Pacific

Navigating the Storm: 20 Defensive Dividend Stocks to Weather a Government Shutdown

Navigating the Storm: 20 Defensive Dividend Stocks to Weather a Government Shutdown

Johnson & Johnson's Unwavering Commitment to Innovation: A Glimpse into the Future of Healthcare

Johnson & Johnson's Unwavering Commitment to Innovation: A Glimpse into the Future of Healthcare

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

Kenvue's Rollercoaster: How Tylenol Maker's Shares Defied Trump's Autism Claims

Kenvue's Rollercoaster: How Tylenol Maker's Shares Defied Trump's Autism Claims

Tylenol's Triumphant Rebound: How Scientific Truth Silenced Unfounded Claims and Propelled J&J's Stock

Tylenol's Triumphant Rebound: How Scientific Truth Silenced Unfounded Claims and Propelled J&J's Stock

Load more